Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer

Journal of Molecular Endocrinology

Volumn 31, Issue 3, 2003, Pages 461-471

  Devost, D ^a   Zingg, Hans H ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LIGAND; LUCIFERASE; MARKER; MYC PROTEIN; OXYTOCIN RECEPTOR; PROTEIN ANTIBODY; YELLOW FLUORESCENT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; DISULFIDE BOND; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; BRADYKININ; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; DIMERIZATION; ENERGY TRANSFER; FEMALE; HUMANS; IMMUNOPRECIPITATION; LUMINESCENT MEASUREMENTS; OXYTOCIN; RECEPTORS, OXYTOCIN; SIGNAL TRANSDUCTION;

EID: 0347359063     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0310461     Document Type: Article

References (27)

1. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M & Bouvier M 2000 Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). PNAS 97 3684-3689.
2. Angers S, Salahpour A & Bouvier M 2002 Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annnal Review of Pharmacology and Toxicology 42 409-435.
3. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M & Jockers R 2002 Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. Journal of Biological Chemistry 277 21522-21528.
4. Breton C, Chellil H, Kabbaj-Benmansour M, Carnazzi E, Seyer R, Phalipou S, Morin D, Durroux T, Zingg H, Barberis C et al. 2001 Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor. Journal of Biological Chemistry 276 26931-26941.
5. Chen DC, Chan WY & Manning M 1994 Agonist and antagonist specificities of decidual prostaglandin-releasing and myometrial uterotonic oxytocin receptors in pregnant rats. Journal of Reproduction and Fertility 102 337-343.
6. Cvejic S & Devi LA 1997 Dimerization of the delta opioid receptor: implication for a role in receptor internalization. Journal of Biological Chemistry 272 26959-26964.
7. Eidne KA 2002 Application of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells. Trends in Endocrinology and Metabolism 13 415-421.
8. Fanelli F, Barbier P, Zanchetta D, de Benedetti PG & Chini B 1999 Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Molecular Pharmacology 56 214-225.
9. Fuchs A-R, Helmer H, Behrens O, Liu H-C, Antonian L, Chang S & Fields M 1992 Oxytocin and bovine parturition: a steep rise in endometrial oxytocin receptors precedes onset of labor. Biology of Reproduction 47 937-944.
10. Hawtin SR, Howard HC & Wheatley M 2001 Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes. Biochemical Journal 354 465-472.
11. Hebert TE, Moffett S, Morello J-P, Loisel TP, Bichet DG, Barret C & Bouvier M 1996 A peptide derived from a beta 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. Journal of Biological Chemistry 271 16384-16392.
12. Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, Labbe-Jullie C, Bouvier M & Marullo S 2002 Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. Journal of Biological Chemistry 277 34666-34673.
13. Ku CY, Qian A, Wen Y, Anwer K & Sanborn BM 1995 Oxytocin stimulates myometrial guanosine triphosphatase and phospholipase-C activities via coupling to G alpha q/11. Endocrinology 136 1509-1515.
14. Latif R, Graves P & Davies TF 2002 Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. Journal of Biological Chemistry 277 45059-45067.
15. Patel RC, Kumar U, Lamb DC, Eid JS, Rocheville M, Grant M, Rani A, Hazlett T, Patel SC, Gratton E et al. 2002 Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. PNAS 99 3294-3299.
16. Postina R, Kojro E & Fahrenholz F 1996 Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. Journal of Biological Chemistry 271 31593-31601.
17. Sadeghi HM, Innamorati G, Esqueda E & Birnbaumer M 1998 Processing and ligand-induced modifications of the V2 vasopressin receptor. Advances in Experimental Medicine and Biology 449 339-346.
18. Salahpour A, Angers S & Bouvier M 2000 Functional significance of oligomerization of G-protein-coupled receptors. Trends in Endocrinology and Metabolism 11 163-168.
19. Schneider C, Newman RA, Sutherland DR, Asser U & Greaves MF 1982 A one-step purification of membrane proteins using a high efficiency immunomatrix. Journal of Biological Chemistry 257 10766-10769.
20. Schoneberg T, Yun J, Wenkert D & Wess J 1996 Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO Journal 15 1283-1291.
21. Schoneberg T, Sandig V, Wess J, Gudermann T & Schultz G 1997 Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. Journal of Clinical Investigation 100 1547-1556.
22. Strakova Z & Soloff MS 1997 Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction. American Journal of Physiology 272 E870-E876.
23. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C & Bouvier M 2003 Oxytocin and vasopressin V1a and V2 receptors form constitute homo- and heterodimers during biosynthesis. Molecular Endocrinology 17 677-691.
24. Xu Y, Piston DW & Johnson CH 1999 A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. PNAS 96 151-156.
25. Zeng FY & Wess J 1999 Identification and molecular characterization of M3 muscarinic receptor dimers. Journal of Biological Chemistry 274 19487-19497.
26. Zhu X & Wess J 1998 Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37 15773-15784.
27. Zingg HH & Laporte SA 2003 The oxytocin receptor. Trends in Endocrinology and Metabolism 14 222-227.